Loading...
XNASSINT
Market cap5mUSD
Dec 26, Last price  
4.06USD
1D
9.73%
1Q
18.37%
Jan 2017
-100.00%
IPO
-100.00%
Name

SINTX Technologies Inc

Chart & Performance

D1W1MN
XNAS:SINT chart
P/E
—
P/S
2.08
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
1,046.46%
Rev. gr., 5y
94.24%
Revenues
3m
+337.10%
20,261,45523,065,27222,314,00022,765,00019,453,00015,226,00011,227,00095,000689,000594,000606,000601,0002,627,000
Net income
-8m
L-49.91%
-23,751,170-35,034,669-8,286,000-32,582,000-23,912,000-16,598,000-9,329,000-8,652,000-4,849,000-7,313,000-9,823,000-16,489,000-8,259,000
CFO
-14m
L+37.53%
-14,907,757-9,730,162-9,949,000-14,522,000-9,063,000-7,170,000-4,680,000-9,348,000-6,435,000-9,112,000-10,132,000-10,263,000-14,115,000
Earnings
Jan 21, 2025

Profile

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
URL
https://sintx.com/
IPO date
Feb 11, 2014
Employees
41
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,627
337.10%
601
-0.83%
606
2.02%
Cost of revenue
14,856
12,041
11,226
Unusual Expense (Income)
NOPBT
(12,229)
(11,440)
(10,620)
NOPBT Margin
Operating Taxes
4,450
1,048
Tax Rate
NOPAT
(12,229)
(15,890)
(11,668)
Net income
(8,259)
-49.91%
(16,489)
67.86%
(9,823)
34.32%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,175
3,842
196
BB yield
-311.40%
-0.63%
Debt
Debt current
1,070
898
500
Long-term debt
7,886
4,348
4,296
Deferred revenue
Other long-term liabilities
2
Net debt
5,616
(999)
(9,477)
Cash flow
Cash from operating activities
(14,115)
(10,263)
(10,132)
CAPEX
(530)
(1,405)
(3,739)
Cash from investing activities
(501)
(1,101)
(1,651)
Cash from financing activities
11,711
3,336
705
FCF
(13,538)
(17,165)
(15,681)
Balance
Cash
3,340
6,245
14,273
Long term investments
Excess cash
3,209
6,215
14,243
Stockholders' equity
(270,661)
(262,450)
(249,636)
Invested Capital
283,908
271,043
269,762
ROIC
ROCE
EV
Common stock shares outstanding
22
317
Price
76.28
-96.06%
1,936.00
-84.92%
12,838.00
-59.11%
Market cap
1,662
-99.73%
614,337
 
EV
7,278
613,338
EBITDA
(10,572)
(10,477)
(9,970)
EV/EBITDA
Interest
2
17
25
Interest/NOPBT